Found: 41
Select item for more details and to access through your institution.
C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines.
- Published in:
- Oncogene, 2000, v. 19, n. 42, p. 4864, doi. 10.1038/sj.onc.1203838
- By:
- Publication type:
- Article
FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36430-2
- By:
- Publication type:
- Article
Measuring Tumor Metabolism in Pediatric Diffuse Intrinsic Pontine Glioma Using Hyperpolarized Carbon-13 MR Metabolic Imaging.
- Published in:
- Contrast Media & Molecular Imaging, 2018, p. 1, doi. 10.1155/2018/3215658
- By:
- Publication type:
- Article
New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 136, n. 3, p. 475, doi. 10.1007/s11060-017-2681-8
- By:
- Publication type:
- Article
Combined BRAF and MEK blockade for BRAF-mutant gliomas.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 131, n. 3, p. 495, doi. 10.1007/s11060-016-2333-4
- By:
- Publication type:
- Article
Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 126, n. 3, p. 385, doi. 10.1007/s11060-015-1939-2
- By:
- Publication type:
- Article
Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 110, n. 3, p. 305, doi. 10.1007/s11060-012-0973-6
- By:
- Publication type:
- Article
Future clinical trials in DIPG: bringing epigenetics to the clinic.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00148
- By:
- Publication type:
- Article
ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08823-9
- By:
- Publication type:
- Article
Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma.
- Published in:
- Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-022-01463-z
- By:
- Publication type:
- Article
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis.
- Published in:
- Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-022-01336-5
- By:
- Publication type:
- Article
Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells.
- Published in:
- 2014
- By:
- Publication type:
- journal article
A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell‐of‐origin dependent effects of H3K27M.
- Published in:
- Glia, 2022, v. 70, n. 9, p. 1681, doi. 10.1002/glia.24189
- By:
- Publication type:
- Article
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
- Published in:
- Acta Neuropathologica Communications, 2019, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40478-019-0774-7
- By:
- Publication type:
- Article
CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response.
- Published in:
- 2018
- By:
- Publication type:
- Letter
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas.
- Published in:
- Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01568
- By:
- Publication type:
- Article
WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3429, doi. 10.3390/cancers15133429
- By:
- Publication type:
- Article
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.
- Published in:
- Nature Medicine, 2014, v. 20, n. 12, p. 1394, doi. 10.1038/nm.3716
- By:
- Publication type:
- Article
Characterization of Distinctive In Vivo Metabolism between Enhancing and Non-Enhancing Gliomas Using Hyperpolarized Carbon-13 MRI.
- Published in:
- Metabolites (2218-1989), 2021, v. 11, n. 8, p. 504, doi. 10.3390/metabo11080504
- By:
- Publication type:
- Article
EAG2 potassium channel with evolutionarily conserved function as a brain tumor target.
- Published in:
- Nature Neuroscience, 2015, v. 18, n. 9, p. 1236, doi. 10.1038/nn.4088
- By:
- Publication type:
- Article
An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 108, n. 1, p. 29, doi. 10.1007/s11060-011-0796-x
- By:
- Publication type:
- Article
A human brainstem glioma xenograft model enabled for bioluminescence imaging.
- Published in:
- Journal of Neuro-Oncology, 2010, v. 96, n. 2, p. 151, doi. 10.1007/s11060-009-9954-9
- By:
- Publication type:
- Article
Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 8, p. 1348, doi. 10.1093/neuonc/noab009
- By:
- Publication type:
- Article
LSD1 inhibition in pHGG: the key to unleashing immunotherapy?
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 9, p. 1237, doi. 10.1093/neuonc/noaa171
- By:
- Publication type:
- Article
IMMU-01. NOVEL RNA-TARGETING STRATEGY FOR TREATING T CELL-DRIVEN IMMUNOSUPPRESSION IN HUMAN DIFFUSE INTRINSIC PONTINE GLIOMA.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii92, doi. 10.1093/neuonc/noz036.122
- By:
- Publication type:
- Article
HGG-10. HISTONE H3G34V MUTATION IS SUFFICIENT TO DRIVE DISTINCT GENOMIC H3K36 METHYLATION PATTERNS IN PEDIATRIC GLIOMA.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii88, doi. 10.1093/neuonc/noz036.104
- By:
- Publication type:
- Article
DIPG-26. ACVR1 R206H COOPERATES WITH H3.1K27M IN PROMOTING DIFFUSE INTRINSIC PONTINE GLIOMA PATHOGENESIS.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii74, doi. 10.1093/neuonc/noz036.047
- By:
- Publication type:
- Article
DIPG-11. ACTIVATION OF RAS SIGNALING AND DISTINCT MITOGEN-ACTIVATED PROTEIN KINASES (MAPKs) PROVIDES UNIQUE THERAPEUTIC VULNERABILITIES IN MUTANT HISTONE DIPG.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii70, doi. 10.1093/neuonc/noz036.032
- By:
- Publication type:
- Article
ATRT-02. THERAPEUTIC TARGETING OF EZH2 AND BET BRD4 IN AT/RT.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii63, doi. 10.1093/neuonc/noz036.001
- By:
- Publication type:
- Article
Molecular and translational advances in meningiomas.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. i4, doi. 10.1093/neuonc/noy178
- By:
- Publication type:
- Article
PDTM-36. NEW THERAPEUTIC APPROACH FOR BRAINSTEM GLIOMA: INTRANASAL DELIVERY OF NANOLIPOSOMAL SN-38.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi211, doi. 10.1093/neuonc/noy148.876
- By:
- Publication type:
- Article
PDTM-39. HISTONE H3 MUTATION EFFECTS ON CHROMATIN STRUCTURE AND REGULATION OF GENE TRANSCRIPTION IN PEDIATRIC GLIOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi212, doi. 10.1093/neuonc/noy148.879
- By:
- Publication type:
- Article
PDTM-29. CSF H3F3A K27M CIRCULATING TUMOR DNA COPY NUMBER QUANTIFIES TUMOR GROWTH AND TREATMENT RESPONSE.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi209, doi. 10.1093/neuonc/noy148.870
- By:
- Publication type:
- Article
PDTM-10. NOVEL RNA-TARGETING STRATEGY FOR TREATING T CELL-DRIVEN IMMUNOSUPPRESSION IN HUMAN DIFFUSE INTRINSIC PONTINE GLIOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi205, doi. 10.1093/neuonc/noy148.852
- By:
- Publication type:
- Article
Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 11, p. 1519, doi. 10.1093/neuonc/now106
- By:
- Publication type:
- Article
BIOLOGICALLY-BASED THERAPEUTICS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii26, doi. 10.1093/neuonc/nou208.13
- By:
- Publication type:
- Article
Targeting Wee1 for the treatment of pediatric high-grade gliomas.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 3, p. 352, doi. 10.1093/neuonc/not220
- By:
- Publication type:
- Article
Expression of miR-124 inhibits growth of medulloblastoma cells.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 1, p. 83, doi. 10.1093/neuonc/nos281
- By:
- Publication type:
- Article
Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 4, p. 366, doi. 10.1093/neuonc/nop033
- By:
- Publication type:
- Article
Analysis of Cdc2 and Cyclin D1 expression in breast cancer by immunoblotting.
- Published in:
- Breast Cancer (13406868), 1997, v. 4, n. 1, p. 17, doi. 10.1007/BF02967050
- By:
- Publication type:
- Article